Allegra Approved for Over-the-Counter Sale

Beginning in March

TUESDAY, Jan. 25 (HealthDay News) -- Sanofi-Aventis' prescription non-drowsy antihistamine, Allegra (fexofenadine), has been approved by the U.S. Food and Drug Administration for over-the-counter sale, the company said Tuesday.

The drug will be available in its original prescription strengths starting in March for people aged 2 years and older, according to a news release from Sanofi and its U.S. consumer division, Chattem Inc. A version that combines Allegra with a decongestant, Allegra-D, will be available at the same time for people aged 12 and older without a prescription at the pharmacy counter, the companies said.

More than 40 million Americans have indoor or outdoor allergies, according to the drug makers.

More information

To learn more about this drug, visit the U.S. National Library of Medicine.

Copyright © 2011 HealthDay. All rights reserved.

Powered by

Featured Jobs



Benefits of Membership

FREE E-Newsletters
Sign up for our free enewsletters to stay up-to-date in your area of practice - or take a look at an archive of prior issues

CESaver
Join our CESaver program to earn up to 100 contact hours for only $34.95
Register Now

Lippincott's NursingCenter.com
Explore a world of online resources

Become a Member